Noah Goodman
Patrimonio netto: 5 M $ in data 30/06/2026
Patrimonio netto: 5 M $ in data 30/06/2026
Mr. Noah Goodman is a Chief Business Officer at Kymera Therapeutics, Inc. Mr. Goodman was previously employed as a President & Chief Business Officer by Chroma Medicine, Inc., an Executive Director & Head-Business Development by Cadent Therapeutics, Inc., and a Head-Business Development by Spark Therapeutics, Inc. He received his undergraduate degree from the University of Michigan and an MBA from The Wharton School of the University of Pennsylvania.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/07/2026 | 47.179 ( 0,06% ) | 5 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Corporate Officer/Principal | 09/04/2025 |
| Società | Posizione | Fine |
|---|---|---|
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Presidente | 01/04/2025 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Direttore/Membro del Consiglio | 01/03/2021 |
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale